{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-022279","form_type":"8-K","ticker":"IXHL","cik":"0001873875","company_name":"Incannex Healthcare Inc.","filed_at":"2025-03-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.440370+00:00","generated_at":"2026-05-25T02:10:18.032103+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Incannex prices $12.5M private placement at $1.08/share to fund OSA trial","bullets":["Gross proceeds $12.5M from 11.57M shares at $1.08 plus Series A warrants at $2.16.","Net proceeds ~$11.3M after placement agent fees and expenses.","Funds IHL-42X Phase 2/3 OSA study completion and Phase 3 expansion.","Proceeds also repay outstanding convertible debentures and for working capital.","Transaction closed March 10, 2025; R.F. Lafferty as sole placement agent."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-022279","json":"https://secwatch.observer/filing/0001213900-25-022279.json","markdown":"https://secwatch.observer/filing/0001213900-25-022279.md","text":"https://secwatch.observer/filing/0001213900-25-022279.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1873875/000121390025022279/0001213900-25-022279-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1873875/000121390025022279/ea0233697-8k_incannex.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-25T02:10:18.032103+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}